Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Genome Sequencing Of Schistosomiasis Parasites Could Promote Drug Development
Researchers have sequenced the genomes of two parasites that cause bilharzia or schistosomiasis - a disease transmitted by water-borne snails that affects more than 200 million people worldwide - "revealing potential weaknesses that could be exploited by drug developers," Nature reports (Smith, 7/15).

Male Circumcision Does Not Appear To Reduce HIV Transmission Risk To Female Partners
Although several studies have shown that circumcision, removal of the foreskin which contains cells that are particularly susceptible to HIV, appears to reduce a man"s risk of contracting HIV from his female sex partner, it does not reduce the female sex partners" risk of contracting the virus, according to a study in the Lancet, Reuters reports. Maria Wawer of Johns Hopkins University and colleagues in Uganda followed 922 HIV-positive, uncircumcised men ages 15 to 49. Some of the men immediately underwent a circumcision, and some had the procedure two years later. The researchers also followed 163 female partners of the men.The researchers decided to end the study early when they found that male circumcision did not convey the expected benefits to women. The study also found that men"s partners were no less likely to contract other sexually transmitted infections, except for trichomonas.However, based on observational studies, researchers say that circumcision is so effective in protecting men that it will still likely benefit women indirectly by reducing circulation of the virus in general (Fox, Reuters, 7/16).
News of the day
Novavax Announces Selection Of A Respiratory Syncytial Virus Vaccine Candidate For Advanced Preclinical Studies
Novavax, Inc. (Nasdaq: NVAX) announced final selection of a Respiratory Syncytial Virus (RSV) vaccine candidate that will be advanced into additional preclinical studies to support an Investigational New Drug (IND) application. As previously announced, Novavax has been evaluating a number of RSV vaccine candidates, all of which have successfully induced antibody responses in mice. Novavax scientists have now engineered a new vaccine candidate which has been shown to protect mice against RSV disease and can be produced at sufficient yields to allow commercial manufacture. This new candidate is directed against a protein on the surface of the virus, the "F" or "fusion" protein, which is the protein that the virus uses to infect and fuse with cells in the respiratory tract and cause disease.
Sexual Health

Statistics Show Drop In Births, Lower Demand For Infertility Services During Recession

More people in the Atlanta area and across the U.S. are delaying pregnancy in a possible reaction to the current economic recession, leading to a decline in the number of couples seeking infertility treatments, the Atlanta Journal-Constitution reports. According to the Journal-Constitution, 13 states saw a decrease in the number of recorded births in 2008 compared with 2007. The Georgia Hospital Association reports that there were 5,352 fewer recorded births in Georgia in 2008 than in 2007. Mark Perloe of Georgia Reproductive Specialists said there has been a 20% decline in the number of people seeking infertility services. To retain business during the economic downturn, Perloe said Georgia Reproductive Specialists is offering a discount on select services of as much as 70%.Elisabeth Burgess, a Georgia State University sociology professor who focuses on families, said, "In times of economic downturns, different people react in different ways." For some people, "[f]amily becomes more important, so you might decide to have a child." The Journal-Constitution reports that one cycle of treatment can cost $15,000 or more, which some people pay for through credit, retirement savings or home equity loans. Evelina Sterling, co-author of a book on budgeting finances for infertility treatments, said that 70% of infertility patients cover the costs of the treatments completely out of pocket. She added that some older infertility patients "can"t wait on" the economy to recover to start a family.Carol Hogue, a professor of maternal and child health at Emory University, said there has been a "very predictable" pattern of reduced births during periods of economic recessions dating back to the Great Depression. The Journal-Constitution reports that some people delay planned pregnancy because of concerns over job security, health insurance, income and the cost of raising a child. Statistics from USDA show that the average middle-class family will pay $11,000 to raise a child in the first year, with the largest portion of that cost going to child care. The Agency for Healthcare Research and Quality reported in 2007 -- the latest year for which data are available -- that prenatal care and routine delivery costs about $7,600 after insurance (Cash, Atlanta Journal-Constitution, 5/24). Reprinted with kind permission from http://www.nationalpartnership.org. You can view the entire Daily Women"s Health Policy Report, search the archives, or sign up for email delivery here. The Daily Women"s Health Policy Report is a free service of the National Partnership for Women & Families, published by The Advisory Board Company. © 2009 The Advisory Board Company. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009